The use of Omegaven in treating parenteral nutrition-associated liver disease.
about
The relationship between the parenteral dose of fish oil supplementation and the variation of liver function tests in hospitalized adult patientsDocosahexaenoic acid liposomes for targeting chronic inflammatory diseases and cancer: an in vitro assessment.New advances in the management of children with intestinal failure.
P2860
The use of Omegaven in treating parenteral nutrition-associated liver disease.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The use of Omegaven in treating parenteral nutrition-associated liver disease.
@ast
The use of Omegaven in treating parenteral nutrition-associated liver disease.
@en
The use of Omegaven in treating parenteral nutrition-associated liver disease.
@nl
type
label
The use of Omegaven in treating parenteral nutrition-associated liver disease.
@ast
The use of Omegaven in treating parenteral nutrition-associated liver disease.
@en
The use of Omegaven in treating parenteral nutrition-associated liver disease.
@nl
prefLabel
The use of Omegaven in treating parenteral nutrition-associated liver disease.
@ast
The use of Omegaven in treating parenteral nutrition-associated liver disease.
@en
The use of Omegaven in treating parenteral nutrition-associated liver disease.
@nl
P2093
P2860
P356
P1476
The use of Omegaven in treating parenteral nutrition-associated liver disease.
@en
P2093
P2860
P2888
P304
P356
10.1038/JP.2010.182
P478
31 Suppl 1
P577
2011-04-01T00:00:00Z
P6179
1052308405